Aura Biosciences, Inc. Proceeds from (Payments for) Other Financing Activities
Aura Biosciences, Inc. (AURA) reported Proceeds from (Payments for) Other Financing Activities of -$15.00 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2023-03-15.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromPaymentsForOtherFinancingActivities · last filed 2023-03-15
- Aura Biosciences, Inc. proceeds from (payments for) other financing activities for the quarter ending 2021-03-31 was -$9.00K.
- Aura Biosciences, Inc. proceeds from (payments for) other financing activities for the quarter ending 2020-12-31 was -$9.00K.
- Aura Biosciences, Inc. proceeds from (payments for) other financing activities for fiscal 2021 was -$15.00K.
- Aura Biosciences, Inc. proceeds from (payments for) other financing activities for fiscal 2020 was -$34.00K.
| Period end | Proceeds from (Payments for) Other Financing Activities 3 month | Proceeds from (Payments for) Other Financing Activities 6 month | Proceeds from (Payments for) Other Financing Activities 9 month | Proceeds from (Payments for) Other Financing Activities 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$15.00K 10-K · filed 2023-03-15 | |||
| 2021-03-31 | -$9.00K 10-Q · filed 2022-05-12 | -$18.00K derived: sum of 2 quarters · filed 2022-05-12 | ||
| 2020-12-31 | -$9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-23 | -$34.00K 10-K · filed 2022-03-23 | ||
| 2020-09-30 | -$25.00K 10-Q · filed 2021-11-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Allogene Therapeutics, Inc. (ALLO) | United States | $0.574B | -4.33 |
| Prime Medicine, Inc. (PRME) | United States | $0.557B | -3.54 |
| 4D Molecular Therapeutics, Inc. (FDMT) | United States | $0.733B | -4.10 |
| Autolus Therapeutics plc (AUTL) | $0.506B | -1.52 | |
| Entera Bio Ltd. (ENTX) | $0.485B | ||
| REGENXBIO Inc. (RGNX) | United States | $0.477B | -3.30 |
| Solid Biosciences Inc. (SLDB) | United States | $0.802B | -5.07 |
| Tectonic Therapeutic, Inc. (TECX) | United States | $0.469B | -7.68 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B | |
| Eikon Therapeutics, Inc. (EIKN) | United States | $0.446B |